Rationale and Ethical Assessment of an Oropharyngeal Gonorrhea Controlled Human Infection Model
- PMID: 39825788
- PMCID: PMC11998581
- DOI: 10.1093/infdis/jiaf029
Rationale and Ethical Assessment of an Oropharyngeal Gonorrhea Controlled Human Infection Model
Abstract
Infection with Neisseria gonorrhoeae, the causative agent of gonorrhea, causes significant morbidity worldwide and can have long-term impacts on reproductive health. The greatest global burden of gonorrhea occurs in low- and middle-income settings. Global public health significance is increasing due to rising antimicrobial resistance, which threatens future gonorrhea management. The oropharynx is an important asymptomatic reservoir for gonorrhea transmission and a high-risk site for development of antimicrobial resistance and treatment failure. Controlled human infection model (CHIM) studies using N gonorrhoeae may provide a means to accelerate the development of urgently needed therapeutics, vaccines, and other biomedical prevention strategies. A gonorrhea urethritis CHIM has been used since the 1980s with no reported serious adverse events. Here, we describe the rationale for an oropharyngeal gonorrhea CHIM, including analysis of potential ethical issues that should inform the development of this novel study design.
Keywords: antimicrobial resistance; controlled human infection model; ethics; gonorrhea; sexually transmitted infection.
© The Author(s) 2025. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Conflict of interest statement
Potential conflicts of interest. All authors: No reported conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
References
-
- Unemo M, Seifert HS, Hook EW 3rd, Hawkes S, Ndowa F, Dillon JR. Gonorrhoea. Nat Rev Dis Primers 2019; 5:79. - PubMed
-
- Sawatzky P, Martin I, Thorington R, Alexander D. Disseminated gonococcal infections in Manitoba, Canada: 2013 to 2020. Sex Transm Dis 2022; 49:831–7. - PubMed
-
- Ochsendorf FR. Sexually transmitted infections: impact on male fertility. Andrologia 2008; 40:72–5. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
